| pubmed-article:19196721 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:19196721 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:19196721 | lifeskim:mentions | umls-concept:C0018801 | lld:lifeskim |
| pubmed-article:19196721 | lifeskim:mentions | umls-concept:C0162638 | lld:lifeskim |
| pubmed-article:19196721 | lifeskim:mentions | umls-concept:C0220901 | lld:lifeskim |
| pubmed-article:19196721 | lifeskim:mentions | umls-concept:C2745888 | lld:lifeskim |
| pubmed-article:19196721 | lifeskim:mentions | umls-concept:C1522609 | lld:lifeskim |
| pubmed-article:19196721 | lifeskim:mentions | umls-concept:C1554112 | lld:lifeskim |
| pubmed-article:19196721 | lifeskim:mentions | umls-concept:C0205179 | lld:lifeskim |
| pubmed-article:19196721 | pubmed:issue | 7 | lld:pubmed |
| pubmed-article:19196721 | pubmed:dateCreated | 2009-4-2 | lld:pubmed |
| pubmed-article:19196721 | pubmed:abstractText | Apoptosis plays an important role in the progression of heart failure (HF). The purpose of this study was to assess whether the pro-apoptotic molecules apoptosis-stimulating fragment (FAS, CD95/APO-1) and tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) predict event-free survival of HF patients. | lld:pubmed |
| pubmed-article:19196721 | pubmed:language | eng | lld:pubmed |
| pubmed-article:19196721 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19196721 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:19196721 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19196721 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19196721 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19196721 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19196721 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19196721 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:19196721 | pubmed:month | Apr | lld:pubmed |
| pubmed-article:19196721 | pubmed:issn | 1522-9645 | lld:pubmed |
| pubmed-article:19196721 | pubmed:author | pubmed-author:RichterBernha... | lld:pubmed |
| pubmed-article:19196721 | pubmed:author | pubmed-author:ZornGerlindeG | lld:pubmed |
| pubmed-article:19196721 | pubmed:author | pubmed-author:HuberKurtK | lld:pubmed |
| pubmed-article:19196721 | pubmed:author | pubmed-author:WojtaJohannJ | lld:pubmed |
| pubmed-article:19196721 | pubmed:author | pubmed-author:BergerRudolfR | lld:pubmed |
| pubmed-article:19196721 | pubmed:author | pubmed-author:PacherRichard... | lld:pubmed |
| pubmed-article:19196721 | pubmed:author | pubmed-author:HülsmannMarti... | lld:pubmed |
| pubmed-article:19196721 | pubmed:author | pubmed-author:NiessnerAlexa... | lld:pubmed |
| pubmed-article:19196721 | pubmed:author | pubmed-author:MörtlDeddoD | lld:pubmed |
| pubmed-article:19196721 | pubmed:author | pubmed-author:HohensinnerPh... | lld:pubmed |
| pubmed-article:19196721 | pubmed:author | pubmed-author:RychliKathrin... | lld:pubmed |
| pubmed-article:19196721 | pubmed:author | pubmed-author:NeuholdStepha... | lld:pubmed |
| pubmed-article:19196721 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:19196721 | pubmed:volume | 30 | lld:pubmed |
| pubmed-article:19196721 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:19196721 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:19196721 | pubmed:pagination | 789-96 | lld:pubmed |
| pubmed-article:19196721 | pubmed:meshHeading | pubmed-meshheading:19196721... | lld:pubmed |
| pubmed-article:19196721 | pubmed:meshHeading | pubmed-meshheading:19196721... | lld:pubmed |
| pubmed-article:19196721 | pubmed:meshHeading | pubmed-meshheading:19196721... | lld:pubmed |
| pubmed-article:19196721 | pubmed:meshHeading | pubmed-meshheading:19196721... | lld:pubmed |
| pubmed-article:19196721 | pubmed:meshHeading | pubmed-meshheading:19196721... | lld:pubmed |
| pubmed-article:19196721 | pubmed:meshHeading | pubmed-meshheading:19196721... | lld:pubmed |
| pubmed-article:19196721 | pubmed:meshHeading | pubmed-meshheading:19196721... | lld:pubmed |
| pubmed-article:19196721 | pubmed:meshHeading | pubmed-meshheading:19196721... | lld:pubmed |
| pubmed-article:19196721 | pubmed:meshHeading | pubmed-meshheading:19196721... | lld:pubmed |
| pubmed-article:19196721 | pubmed:meshHeading | pubmed-meshheading:19196721... | lld:pubmed |
| pubmed-article:19196721 | pubmed:meshHeading | pubmed-meshheading:19196721... | lld:pubmed |
| pubmed-article:19196721 | pubmed:meshHeading | pubmed-meshheading:19196721... | lld:pubmed |
| pubmed-article:19196721 | pubmed:meshHeading | pubmed-meshheading:19196721... | lld:pubmed |
| pubmed-article:19196721 | pubmed:meshHeading | pubmed-meshheading:19196721... | lld:pubmed |
| pubmed-article:19196721 | pubmed:meshHeading | pubmed-meshheading:19196721... | lld:pubmed |
| pubmed-article:19196721 | pubmed:meshHeading | pubmed-meshheading:19196721... | lld:pubmed |
| pubmed-article:19196721 | pubmed:meshHeading | pubmed-meshheading:19196721... | lld:pubmed |
| pubmed-article:19196721 | pubmed:meshHeading | pubmed-meshheading:19196721... | lld:pubmed |
| pubmed-article:19196721 | pubmed:meshHeading | pubmed-meshheading:19196721... | lld:pubmed |
| pubmed-article:19196721 | pubmed:meshHeading | pubmed-meshheading:19196721... | lld:pubmed |
| pubmed-article:19196721 | pubmed:year | 2009 | lld:pubmed |
| pubmed-article:19196721 | pubmed:articleTitle | Prognostic value of apoptosis markers in advanced heart failure patients. | lld:pubmed |
| pubmed-article:19196721 | pubmed:affiliation | Division of Cardiology, Department of Internal Medicine II, Medical University of Vienna, Waehringer Guertel 18-20, Vienna, Austria. | lld:pubmed |
| pubmed-article:19196721 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:19196721 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:19196721 | pubmed:publicationType | Multicenter Study | lld:pubmed |
